TIBER CREEK GROUP

Lobbying for AMGEN INC

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 17, 2026

Lobbying activity 2

Medicare/Medicaid

Issues related to Medicare and Medicaid drug pricing; Issues related to biosimilar access and affordability.

Health Issues

Issues related to the 340B Program - Public Health Service Act (PL 78-410).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.